Nyresvigt kliniske forsøg i Arizona
6 studier for Nyresvigt søger deltagere på steder i Arizona.
Byer i Arizona
Officiel studietekst (engelsk)
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
- Arizona Clinical Trials - Chandler, Chandler
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 84 · Alle køn · Opdateret 1. okt. 2026 · NCT07763418Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- AKDHC Medical, Glendale
- Kidney Disease Medical Group, Glendale
- AKDHC Medical, Phoenix
- og 2 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961REgulatory T Cell Therapy to Achieve Immunosuppression REduction
- Mayo Clinic in Arizona, Phoenix
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 27. apr. 2026 · NCT06552169Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Southwest Kidney Institute, Phoenix
- AKDHC Medical Research Services, Phoenix
- AKDHC Center Tucson, Tucson
Rekrutterer
Alder 18 til 84 · Alle køn · Opdateret 13. apr. 2026 · NCT06190717SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- AKDHC Bullhead City, Bullhead City
- AKDHC Marana Surgery Center, Marana
- Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center, Phoenix
- og 1 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06001827A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- AKDHC Medical Research Services, LLC, Phoenix
Rekrutterer
Alder 18 til 90 · Alle køn · Opdateret 22. dec. 2025 · NCT04671771Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.